news
01-22-2019, 03:45 PM
Johnson & Johnson tops fourth-quarter expectations but signals sales to slow this year (https://www.cnbc.com/2019/01/22/johnson-and-johnson-q4-earnings-2018.html) CNBCSales of psoriasis treatments and cancer drugs helped Johnson & Johnson beat Wall Street analysts' fourth-quarter earnings and revenue expectations.
View full coverage on Google News (https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpyaS 1qQWpZQU1FYW9WY283T1FPM0NLQUFQAQ?oc=5)
More... (https://www.cnbc.com/2019/01/22/johnson-and-johnson-q4-earnings-2018.html)
View full coverage on Google News (https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWpyaS 1qQWpZQU1FYW9WY283T1FPM0NLQUFQAQ?oc=5)
More... (https://www.cnbc.com/2019/01/22/johnson-and-johnson-q4-earnings-2018.html)